| 查看: 748 | 回复: 0 | |||
ienjoysun银虫 (著名写手)
|
[交流]
FDA Releases Draft Guidance on Using the Inactive Ingredient Database
|
|
FDA Releases Draft Guidance on Using the Inactive Ingredient Database The draft guidance provides industry with a guide for using the database to assist in the development of drug products. Jul 10, 2019 By Pharmaceutical Technology Editors On July 10, 2019, FDA published draft guidance for public comment on the use of the Inactive Ingredient Database (IID). The guidance document provides information on how to use the IID when choosing inactive ingredients in the development of new drug products. The guidance also supports the agency’s efforts in the promotion of generic drugs as part of its Drug Competition Action Plan. The guidance also describes how the agency uses the IID to support the safety of inactive ingredients. It describes the structure of the IID, the process for adding ingredients to the IID, and how information is presented in the database, which gives users a better understanding of how to use the information. The IDD lists information on inactive ingredients used in FDA-approved drug products. Once an inactive ingredient is used in an approved drug for a specific route of administration it is not considered novel; therefore, the ingredient may not require extensive review by the agency the next time it is used in a new product. Source: FDA |
回复此楼» 猜你喜欢
求助 苯磷硫胺JP
已经有0人回复
-
100金币 阿莫西林克拉维酸钾片BP药典中提到的克拉维酸聚合物具体结构式是啥？
已经有2人回复
-
药理学论文润色/翻译怎么收费?
已经有52人回复
-
膳食补充剂合规性交流
已经有0人回复
-
一志愿浙大药学求调剂
已经有1人回复
-
高温高压反应求助
已经有4人回复
-
药学B区求调剂
已经有4人回复
-
重庆医科大学-人工智能医学学院
已经有0人回复
-
重庆医科大学-人工智能医学学院
已经有1人回复
-
丽水学院材料与能源工程学院招收调剂！（可调剂专业范围广）
已经有0人回复
-
晴川万里新书
已经有4人回复